dopamine agonists
Showing 1 - 25 of 1,399
Parkinson Disease Trial in Nashville (Pramipexole, Placebo)
Recruiting
- Parkinson Disease
- Pramipexole
- Placebo
-
Nashville, TennesseeVanderbilt University Medical Center
May 2, 2022
Problem Gambling Among Young First-episode Psychosis
Recruiting
- Gambling Disorder
- Psychotic Disorders
- Dopamine partial agonists
- +5 more
-
Montreal, Quebec, Canada
- +1 more
Jan 16, 2023
Impulse Control Disorder Trial in Korea, Republic of (Levodopa/Carbidopa(200mg/50mg), Dopaminergic Agonists)
Completed
- Impulse Control Disorder
- Levodopa/Carbidopa(200mg/50mg)
- Dopaminergic Agonists
-
Anyang, Korea, Republic of
- +4 more
Mar 9, 2021
Prolactinoma, Prolactin-Producing Pituitary Tumor Trial in Amsterdam-Zuidoost, Delft, Leiden (Endoscopic trans-sphenoidal
Recruiting
- Prolactinoma
- Prolactin-Producing Pituitary Tumor
- Endoscopic trans-sphenoidal adenoma resection
- Dopamine Agonists
-
Amsterdam-Zuidoost, Noord-Holland, Netherlands
- +2 more
Jul 17, 2020
Parkinson Disease, Treatment Adherence Trial in Ankara (Levodopa)
Enrolling by invitation
- Parkinson Disease
- Treatment Adherence
-
Ankara, TurkeyAnkara Atatürk Sanatorium Training and Research Hospital
Oct 30, 2023
Chronic Anergic-anhedonic Depression Open Trial
Recruiting
- Depressive Disorder, Treatment-Resistant
-
Strasbourg, FranceCENTRE DE NEUROMODULATION NON INVASIVE DE STRASBOURG (CEMNIS) -
Oct 25, 2023
Parkinson Disease Trial in Lund, Cambridge (STEM-PD)
Recruiting
- Parkinson Disease
- STEM-PD
-
Lund, Sweden
- +1 more
Dec 7, 2022
Idiopathic Parkinson's Disease Trial in Pozzilli (PD patients H&Y=1.5-2 Medications ON, PD patients H&Y=1.5-2 Medications OFF,
Recruiting
- Idiopathic Parkinson's Disease
- PD patients H&Y=1.5-2 Medications ON
- +4 more
-
Pozzilli, Isernia, ItalyIRCSS Neuromed Hospital
May 18, 2022
Vigor and the LDR in Parkinson Disease
Recruiting
- Parkinson Disease
- carbidopa/levodopa, as prescribed by treating physician
-
Ann Arbor, MichiganUniversity of Michigan
Dec 1, 2022
Clinical Features Associated With Restless Legs Syndrome.
Recruiting
- Restless Legs Syndrome
-
Montpellier, FranceUhmontpellier
Sep 18, 2021
P2X7 Receptor, Inflammation and Neurodegenerative Diseases
Completed
- Neuro-Degenerative Disease
- Memantine, Dopamine receptor-agonists
-
Pisa, ItalyUniversity of Pisa
Aug 10, 2019
Restless Legs Syndrome Trial in Bordeaux (other, behavioral, device)
Not yet recruiting
- Restless Legs Syndrome
- Clinical assessment
- +3 more
-
Bordeaux, FranceCHU de Bordeaux - Neurophysiologie Clinique de l'Enfant et de l'
Jan 13, 2023
Traumatic Brain Injury Trial in Albuquerque (Repetitive Transcranial Magnetic Stimulation)
Recruiting
- Traumatic Brain Injury
- Repetitive Transcranial Magnetic Stimulation
-
Albuquerque, New MexicoUniversity of New Mexico Domenici Hall
Jul 29, 2022
Motivation, Memory, Self-regulation Trial (Ventral tegmental area of dopaminergic midbrain (VTA) fMRI neurofeedback)
Not yet recruiting
- Motivation
- +2 more
- Ventral tegmental area of dopaminergic midbrain (VTA) fMRI neurofeedback
- (no location specified)
Jun 26, 2023
DTx Algorithms for Personalized Parkinson's Disease Treatment
Not yet recruiting
- Parkinson Disease
- Smartwatch Garmin Vivosmart [wearable sensor]
- +2 more
-
Roma, Italy
- +2 more
Jun 13, 2023
Parkinson Disease Trial in Bern, Geneva (Dopaminergic OFF-drug state, Dopaminergic ON-drug state)
Recruiting
- Parkinson Disease
- Dopaminergic OFF-drug state
- Dopaminergic ON-drug state
-
Bern, Switzerland
- +3 more
Jan 11, 2023
Hyperprolactinemia, Prolactinoma Trial in New York (Ropinirole)
Completed
- Hyperprolactinemia
- Prolactinoma
-
New York, New YorkColumbia University Medical Center
Jul 9, 2021
in Vitro Fertilization, Poor Responder Trial in Toronto (metoclopramide)
Withdrawn
- in Vitro Fertilization
- Poor Responder
-
Toronto, Ontario, CanadaMount Sinai Hospital
Apr 7, 2022
Lactation Suppressed Trial in Stanford (Cabergoline 1 MG, Placebo)
Active, not recruiting
- Lactation Suppressed
- Cabergoline 1 MG
- Placebo
-
Stanford, CaliforniaStanford University
Jul 7, 2022
Parkinson Disease, Memory Impairment Trial in Beijing (Madopar monotherapy, senfrol monotherapy, monotherapy)
Recruiting
- Parkinson Disease
- Memory Impairment
- Madopar monotherapy
- +2 more
-
Beijing, ChinaPeking University Third Hospital
Jul 8, 2021
Parkinson Trial in Boston (Surface EMG, MRI and PET Scan, Surface EMG)
Terminated
- Parkinson
- Surface EMG, MRI and PET Scan
- Surface EMG
-
Boston, MassachusettsSpaulding Rehabilitation Hospital
Sep 27, 2021
Sensorimotor Integration in Monogenic Parkinson-dystonia
Recruiting
- Parkinson
- +5 more
- Transcranial magnetic stimulation (TMS)
- +3 more
-
Lübeck, Schleswig-Holstein, GermanyInstitute of Systems Motor Science Lübeck
Jan 27, 2023
Parkinson Disease Trial in France (Apomorphine, Dopaminergic Agonist + Apomorphine)
Recruiting
- Parkinson Disease
- Apomorphine
- Dopaminergic Agonist + Apomorphine
-
Marseille, France
- +6 more
Jul 2, 2021
Parkinson Disease Trial in Prague, Bern (Dopaminergic OFF drug state, DBS OFF state, Dopaminergic ON drug state)
Recruiting
- Parkinson Disease
- Dopaminergic OFF drug state
- +3 more
-
Prague, Czechia
- +1 more
Feb 28, 2023